Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach

The adverse impact of common diseases like diabetes mellitus and acute hyperglycemia on morbidity and mortality from myocardial infarction (MI) has been well documented over the past years of research. In the clinical setting, the relationship between blood glucose and mortality appears linear, with...

Full description

Bibliographic Details
Main Authors: Katharina Feige, Sebastian Roth, René M’Pembele, Anna Galow, Sarah Koenig, Martin Stroethoff, Annika Raupach, Giovanna Lurati Buse, Alexander M. Mathes, Markus W. Hollmann, Ragnar Huhn, Carolin Torregroza
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/23/14557
_version_ 1797463165408116736
author Katharina Feige
Sebastian Roth
René M’Pembele
Anna Galow
Sarah Koenig
Martin Stroethoff
Annika Raupach
Giovanna Lurati Buse
Alexander M. Mathes
Markus W. Hollmann
Ragnar Huhn
Carolin Torregroza
author_facet Katharina Feige
Sebastian Roth
René M’Pembele
Anna Galow
Sarah Koenig
Martin Stroethoff
Annika Raupach
Giovanna Lurati Buse
Alexander M. Mathes
Markus W. Hollmann
Ragnar Huhn
Carolin Torregroza
author_sort Katharina Feige
collection DOAJ
description The adverse impact of common diseases like diabetes mellitus and acute hyperglycemia on morbidity and mortality from myocardial infarction (MI) has been well documented over the past years of research. In the clinical setting, the relationship between blood glucose and mortality appears linear, with amplifying risk associated with increasing blood glucose levels. Further, this seems to be independent of a diagnosis of diabetes. In the experimental setting, various comorbidities seem to impact ischemic and pharmacological conditioning strategies, protecting the heart against ischemia and reperfusion injury. In this translational experimental approach from bedside to bench, we set out to determine whether acute and/or prolonged hyperglycemia have an influence on the protective effect of transferred human RIPC-plasma and, therefore, might obstruct translation into the clinical setting. Control and RIPC plasma of young healthy men were transferred to isolated hearts of young male Wistar rats in vitro. Plasma was administered before global ischemia under either short hyperglycemic (HGs Con, HGs RIPC) conditions, prolonged hyperglycemia (HGl Con, HGl RIPC), or under normoglycemia (Con, RIPC). Infarct sizes were determined by TTC staining. Control hearts showed an infarct size of 55 ± 7%. Preconditioning with transferred RIPC plasma under normoglycemia significantly reduced infarct size to 25 ± 4% (<i>p</i> < 0.05 vs. Con). Under acute hyperglycemia, control hearts showed an infarct size of 63 ± 5%. Applying RIPC plasma under short hyperglycemic conditions led to a significant infarct size reduction of 41 ± 4% (<i>p</i> < 0.05 vs. HGs Con). However, the cardioprotective effect of RIPC plasma under normoglycemia was significantly stronger compared with acute hyperglycemic conditions (RIPC vs. HGs RIPC; <i>p</i> < 0.05). Prolonged hyperglycemia (HGl RIPC) completely abolished the cardioprotective effect of RIPC plasma (infarct size 60 ± 7%; <i>p</i> < 0.05 vs. HGl Con; HGl Con 59 ± 5%).
first_indexed 2024-03-09T17:47:46Z
format Article
id doaj.art-bbdb077b84384169b59cb65dc83e3b1f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T17:47:46Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bbdb077b84384169b59cb65dc83e3b1f2023-11-24T11:03:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123231455710.3390/ijms232314557Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational ApproachKatharina Feige0Sebastian Roth1René M’Pembele2Anna Galow3Sarah Koenig4Martin Stroethoff5Annika Raupach6Giovanna Lurati Buse7Alexander M. Mathes8Markus W. Hollmann9Ragnar Huhn10Carolin Torregroza11Department of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937 Cologne, GermanyDepartment of Anesthesiology, Amsterdam University Medical Center (AUMC), Location AMC, Meiberdreef 9, 1105 AZ Amsterdam, The NetherlandsDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyDepartment of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, GermanyThe adverse impact of common diseases like diabetes mellitus and acute hyperglycemia on morbidity and mortality from myocardial infarction (MI) has been well documented over the past years of research. In the clinical setting, the relationship between blood glucose and mortality appears linear, with amplifying risk associated with increasing blood glucose levels. Further, this seems to be independent of a diagnosis of diabetes. In the experimental setting, various comorbidities seem to impact ischemic and pharmacological conditioning strategies, protecting the heart against ischemia and reperfusion injury. In this translational experimental approach from bedside to bench, we set out to determine whether acute and/or prolonged hyperglycemia have an influence on the protective effect of transferred human RIPC-plasma and, therefore, might obstruct translation into the clinical setting. Control and RIPC plasma of young healthy men were transferred to isolated hearts of young male Wistar rats in vitro. Plasma was administered before global ischemia under either short hyperglycemic (HGs Con, HGs RIPC) conditions, prolonged hyperglycemia (HGl Con, HGl RIPC), or under normoglycemia (Con, RIPC). Infarct sizes were determined by TTC staining. Control hearts showed an infarct size of 55 ± 7%. Preconditioning with transferred RIPC plasma under normoglycemia significantly reduced infarct size to 25 ± 4% (<i>p</i> < 0.05 vs. Con). Under acute hyperglycemia, control hearts showed an infarct size of 63 ± 5%. Applying RIPC plasma under short hyperglycemic conditions led to a significant infarct size reduction of 41 ± 4% (<i>p</i> < 0.05 vs. HGs Con). However, the cardioprotective effect of RIPC plasma under normoglycemia was significantly stronger compared with acute hyperglycemic conditions (RIPC vs. HGs RIPC; <i>p</i> < 0.05). Prolonged hyperglycemia (HGl RIPC) completely abolished the cardioprotective effect of RIPC plasma (infarct size 60 ± 7%; <i>p</i> < 0.05 vs. HGl Con; HGl Con 59 ± 5%).https://www.mdpi.com/1422-0067/23/23/14557remote ischemic preconditioningcardioprotectionreperfusion injuryhyperglycemia
spellingShingle Katharina Feige
Sebastian Roth
René M’Pembele
Anna Galow
Sarah Koenig
Martin Stroethoff
Annika Raupach
Giovanna Lurati Buse
Alexander M. Mathes
Markus W. Hollmann
Ragnar Huhn
Carolin Torregroza
Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
International Journal of Molecular Sciences
remote ischemic preconditioning
cardioprotection
reperfusion injury
hyperglycemia
title Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
title_full Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
title_fullStr Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
title_full_unstemmed Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
title_short Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
title_sort influence of short and long hyperglycemia on cardioprotection by remote ischemic preconditioning a translational approach
topic remote ischemic preconditioning
cardioprotection
reperfusion injury
hyperglycemia
url https://www.mdpi.com/1422-0067/23/23/14557
work_keys_str_mv AT katharinafeige influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT sebastianroth influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT renempembele influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT annagalow influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT sarahkoenig influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT martinstroethoff influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT annikaraupach influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT giovannaluratibuse influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT alexandermmathes influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT markuswhollmann influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT ragnarhuhn influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach
AT carolintorregroza influenceofshortandlonghyperglycemiaoncardioprotectionbyremoteischemicpreconditioningatranslationalapproach